You are here

Our homepage has changed its image

16 Sep 2015
Bioiberica
  • New layout
  • Better access to information and products
  • Brand journalism

At Bioiberica we are always improving and innovating. This is why we have redesigned our corporate’s homepage: to easier accessing all the information easier and to better convey the essence of our company.

Now, more than ever, we are firmly committed to brand journalism - to tell the stories and experiences of our customers, of our consumers. Their stories on our products and about the sectors we are in. These are real, first person stories, which will bring our company and our customers one step closer together. This is why we have added to the page header a link giving direct access to the latest stories, as well as to the ones that you liked most.

In addition, the news and current affairs section now plays a greater role-we invite you to visit it more often! Here, you will find the latest news about the company and about the events we attend. Furthermore, we want you to know that very soon we will launch a corporate blog where we will talk about innovation, biotechnology, positive psychology and happiness, among many other themes, in a much more closer and casual way.

Also, from now on, the top-level menu offers a direct link to all of our products.

All of the above is optimized, as it could not be otherwise, for all kinds of devices. We invite you, if you are not already doing so, to surf Bioiberica.

Related News

23 Jan 2024
Bioiberica

On a planet where natural resources are limited and there is increasing concern for the environment, the circular economy has emerged as an innovative and sustainable solution.

16 Oct 2023
Bioiberica

We participated in CPHI 2023 in Barcelona, ​​where we showcased our leadership in scientific research, sustainable development and strategic partnerships for a more resilient future with our portfolio of Active Pharmaceutical and Nutraceutical Ingredients.

4 May 2023
Bioiberica

They've set up Biovall Heparin Science, a joint pharmaceutical innovation project with an investment of 25 million euros and 20 skilled jobs

Bioiberica